University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis : systematic review and economic evaluation

dc.contributor.authorMelendez-Torres, G. J.
dc.contributor.authorAuguste, Peter
dc.contributor.authorArmoiry, Xavier
dc.contributor.authorMaheswaran, Hendramoorthy
dc.contributor.authorCourt, Rachel
dc.contributor.authorMadan, Jason
dc.contributor.authorKan, Alan
dc.contributor.authorLin, Stephanie
dc.contributor.authorCounsell, Carl
dc.contributor.authorPatterson, Jacoby
dc.contributor.authorRodrigues, Jeremy
dc.contributor.authorCiccarelli, Olga
dc.contributor.authorFraser, Hannah
dc.contributor.authorClarke, Aileen
dc.contributor.institutionUniversity of Aberdeen.Chronic Disease Research Groupen
dc.contributor.institutionUniversity of Aberdeen.Grampian Data Safe Haven (DaSH)en
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2017-09-28T09:00:19Z
dc.date.available2017-09-28T09:00:19Z
dc.date.issued2017-09-01
dc.descriptionThe authors gratefully acknowledge the assistance of Ms Karoline Munro and Dr Martin Connock. The authors also acknowledge the work and assistance of Charles Dobson and the RSS Steering Group.en
dc.description.statusPeer revieweden
dc.format.extent352
dc.format.extent2986280
dc.identifier108944767
dc.identifier6b8ae18f-7010-42d1-87c3-e125c6387795
dc.identifier85030177121
dc.identifier.citationMelendez-Torres, G J, Auguste, P, Armoiry, X, Maheswaran, H, Court, R, Madan, J, Kan, A, Lin, S, Counsell, C, Patterson, J, Rodrigues, J, Ciccarelli, O, Fraser, H & Clarke, A 2017, 'Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis : systematic review and economic evaluation', Health Technology Assessment, vol. 21, no. 52, pp. 1-352. https://doi.org/10.3310/hta21520en
dc.identifier.doi10.3310/hta21520
dc.identifier.iss52en
dc.identifier.issn1366-5278
dc.identifier.otherORCID: /0000-0001-6622-7839/work/164505733
dc.identifier.urihttp://hdl.handle.net/2164/9366
dc.identifier.vol21en
dc.language.isoeng
dc.relation.ispartofHealth Technology Assessmenten
dc.subjectR Medicine (General)en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject.lccR1en
dc.titleClinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis : systematic review and economic evaluationen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
3010990.pdf
Size:
2.85 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.31 KB
Format:
Plain Text
Description: